Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008:613:97-106.
doi: 10.1007/978-0-387-74904-4_10.

In vitro analysis of ribozyme-mediated knockdown of an ADRP associated rhodopsin mutation

Dibyendu Chakraborty  1 , Patrick Whalen, Alfred S Lewin, Muna I Naash
Affiliations

In vitro analysis of ribozyme-mediated knockdown of an ADRP associated rhodopsin mutation

Dibyendu Chakraborty et al. Adv Exp Med Biol. 2008.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The sequence and structure of the hammerhead and hairpin ribozyme
Fig. 2
Fig. 2
Retinal structure in VPP transgenics. Histological evaluation (light microscopy) at postnatal day 20 shows retinal degeneration of the VPP+/−/Rho+/+ mice when compared to non-transgenic Rho+/+ littermate. Expression of the VPP transgene on the Rho−/− background resulted in a faster rate of photoreceptor degeneration and an absence of outer segment structures
Fig. 3
Fig. 3
Time course showing the cleavage rate of the VPP target by the ribozymes
Fig. 4
Fig. 4
Cleavage rate of the HP2 (A) and HP3 (B) hairpin ribozyme. The time courses of the cleavage reactions for the mutant and wild-type oligonucleotides are shown
Fig. 5
Fig. 5
HP2 hairpin ribozyme multiple turnover cleavage reaction. (A) An image of the autoradiogram of the HP2 multiple turnover cleavage reaction. (B) A graph of the Eadiee-Hofstee plot used to calculate the kinetic coefficients of the HP2 ribozyme
See this image and copyright information in PMC

References

    1. Blake KR, Murakami A, Miller PS. Inhibition of rabbit globin mRNA translation by sequence-specific oligodeoxyribonucleotides. Biochemistry. 1985;24:6132. - PubMed
    1. Bumcrot D, Manoharan M, Koteliansky V, Sah DW. RNAi therapeutics: a potential new class of pharmaceutical drugs. Nat Chem Biol. 2006;2:711. - PMC - PubMed
    1. Cashman SM, Binkley EA, Kumar-Singh R. Towards mutation-independent silencing of genes involved in retinal degeneration by RNA interference. Gene Ther. 2005;12:1223. - PubMed
    1. Drenser KA, Timmers AM, Hauswirth WW, Lewin AS. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1998;39:681. - PubMed
    1. Dryja TP, Hahn LB, Cowley GS, McGee TL, Berson EL. Mutation spectrum of the rhodopsin gene among patients with autosomal dominant retinitis pigmentosa. Proc Natl Acad Sci U S A. 1991;88:9370. - PMC - PubMed